Immediate Impact
3 from Science/Nature 71 standout
Citing Papers
Ponsegromab for the Treatment of Cancer Cachexia
2024 Standout
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Works of Chee‐Keong Toh being referenced
Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore
2018
Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Chee‐Keong Toh | 990 | 917 | 447 | 71 | 1.8k | |
| Likun Chen | 581 | 779 | 462 | 84 | 1.4k | |
| Sang‐Hee Cho | 480 | 615 | 449 | 136 | 1.8k | |
| Xiuyu Cai | 632 | 974 | 422 | 96 | 2.0k | |
| Dean Lim | 399 | 954 | 687 | 72 | 2.1k | |
| Dinesh Chandra Doval | 653 | 1146 | 313 | 98 | 1.9k | |
| J. B. Vermorken | 722 | 1425 | 601 | 95 | 2.9k | |
| Sang Won Shin | 937 | 1221 | 536 | 119 | 2.4k | |
| Salvatore Pisconti | 426 | 669 | 491 | 96 | 1.6k | |
| Jun‐Eul Hwang | 464 | 638 | 437 | 104 | 1.7k | |
| Swan Swan Leong | 581 | 863 | 247 | 40 | 1.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...